Changes in Prescribing Practices of Dopaminergic Medications in Individuals with Parkinson's Disease by Expert Care Centers from 2010 to 2017: The Parkinson's Foundation Quality Improvement Initiative
Sign Up to like & getrecommendations! Published in 2019 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.12837
Abstract: During the past decade, there has been increasing awareness of the side effects of dopamine agonists (DAs), including impulse control disorders. We hypothesized that there may be a shift toward more conservative use of DAs. read more here.
Keywords: medications individuals; individuals parkinson; prescribing practices; practices dopaminergic ... See more keywords
Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem‐containing medications
Sign Up to like & getrecommendations! Published in 2017 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4215
Abstract: Products containing the sedative/hypnotic zolpidem were subject to Drug Safety Communications (DSCs) in January and May 2013 describing the risk of next‐morning impairment and recommending lower starting doses particularly for women. This study aimed to… read more here.
Keywords: zolpidem; drug safety; changes prescribing; safety communications ... See more keywords
Changes in prescribing habits for the treatment of metastatic renal clear cell carcinoma (mRCC) in Australia
Sign Up to like & getrecommendations! Published in 2021 at "Internal Medicine Journal"
DOI: 10.1111/imj.15419
Abstract: The availability of efficacious systemic therapies for metastatic clear cell renal cell carcinoma has heralded improved survival for Australians. The Pharmaceutical Benefits Schedule registry was interrogated to assess nation‐wide prescribing patterns. Sunitinib remained the most… read more here.
Keywords: cell carcinoma; prescribing habits; changes prescribing; cell ... See more keywords